Market closed

Veru/VERU

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Veru

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Ticker

VERU
Trading on

Industry

Personal Care Products

Employees

189

Veru Metrics

BasicAdvanced
$127M
Market cap
-
P/E ratio
-$0.31
EPS
-0.43
Beta
-
Dividend rate
$127M
-0.43
$1.92
$0.36
510K
3.623
2.9
30.972
33.594
-101.29%
-38.35%
-126.72%
7.426
3.37
4.12
-3.859
-6.20%
-79.78%
-37.37%
441.66%

What the Analysts think about Veru

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Veru stock.

Veru Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Veru Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy VERU

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Veru stock?

Veru (VERU) has a market cap of $127M as of October 13, 2024.

What is the P/E ratio for Veru stock?

The price to earnings (P/E) ratio for Veru (VERU) stock is 0 as of October 13, 2024.

Does Veru stock pay dividends?

No, Veru (VERU) stock does not pay dividends to its shareholders as of October 13, 2024.

When is the next Veru dividend payment date?

Veru (VERU) stock does not pay dividends to its shareholders.

What is the beta indicator for Veru?

Veru (VERU) has a beta rating of -0.43. This means that it has an inverse relation to market volatility.